These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15480536)

  • 1. In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4.
    Hino S; Yamaoka T; Yamashita Y; Yamada T; Hata J; Itakura M
    Diabetologia; 2004 Oct; 47(10):1819-30. PubMed ID: 15480536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
    Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R
    Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia.
    Rane SG; Dubus P; Mettus RV; Galbreath EJ; Boden G; Reddy EP; Barbacid M
    Nat Genet; 1999 May; 22(1):44-52. PubMed ID: 10319860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cytokine-induced cytotoxicity of pancreatic islet cells from transgenic mice expressing the Src-like tyrosine kinase GTK.
    Annerén C; Welsh M
    Mol Med; 2001 May; 7(5):301-10. PubMed ID: 11474576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice expressing Shb adaptor protein under the control of rat insulin promoter exhibit altered viability of pancreatic islet cells.
    Welsh M; Christmansson L; Karlsson T; Sandler S; Welsh N
    Mol Med; 1999 Mar; 5(3):169-80. PubMed ID: 10404514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.
    Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML
    Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of pre-pro-cholecystokinin stimulates beta-cell proliferation in mouse and human islets with retention of islet function.
    Lavine JA; Raess PW; Davis DB; Rabaglia ME; Presley BK; Keller MP; Beinfeld MC; Kopin AS; Newgard CB; Attie AD
    Mol Endocrinol; 2008 Dec; 22(12):2716-28. PubMed ID: 18845673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes.
    Laybutt DR; Weir GC; Kaneto H; Lebet J; Palmiter RD; Sharma A; Bonner-Weir S
    Diabetes; 2002 Jun; 51(6):1793-804. PubMed ID: 12031967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number.
    Martín J; Hunt SL; Dubus P; Sotillo R; Néhmé-Pélluard F; Magnuson MA; Parlow AF; Malumbres M; Ortega S; Barbacid M
    Oncogene; 2003 Aug; 22(34):5261-9. PubMed ID: 12917627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo conditional Pax4 overexpression in mature islet β-cells prevents stress-induced hyperglycemia in mice.
    Hu He KH; Lorenzo PI; Brun T; Jimenez Moreno CM; Aeberhard D; Vallejo Ortega J; Cornu M; Thorel F; Gjinovci A; Thorens B; Herrera PL; Meda P; Wollheim CB; Gauthier BR
    Diabetes; 2011 Jun; 60(6):1705-15. PubMed ID: 21521872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
    Gillam MP; Nimbalkar D; Sun L; Christov K; Ray D; Kaldis P; Liu X; Kiyokawa H
    Oncogene; 2015 Feb; 34(7):932-8. PubMed ID: 24531709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice.
    Miyawaki K; Inoue H; Keshavarz P; Mizuta K; Sato A; Sakamoto Y; Moritani M; Kunika K; Tanahashi T; Itakura M
    Diabetes Res Clin Pract; 2008 Oct; 82(1):33-41. PubMed ID: 18678431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes.
    Yamagata K; Nammo T; Moriwaki M; Ihara A; Iizuka K; Yang Q; Satoh T; Li M; Uenaka R; Okita K; Iwahashi H; Zhu Q; Cao Y; Imagawa A; Tochino Y; Hanafusa T; Miyagawa J; Matsuzawa Y
    Diabetes; 2002 Jan; 51(1):114-23. PubMed ID: 11756330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent expression of HNF6 in islet endocrine cells causes disrupted islet architecture and loss of beta cell function.
    Gannon M; Ray MK; Van Zee K; Rausa F; Costa RH; Wright CV
    Development; 2000 Jul; 127(13):2883-95. PubMed ID: 10851133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 338-bp proximal fragment of the glucose transporter type 2 (GLUT2) promoter drives reporter gene expression in the pancreatic islets of transgenic mice.
    Waeber G; Pedrazzini T; Bonny O; Bonny C; Steinmann M; Nicod P; Haefliger JA
    Mol Cell Endocrinol; 1995 Oct; 114(1-2):205-15. PubMed ID: 8674846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis.
    Miliani de Marval PL; Gimenez-Conti IB; LaCava M; Martinez LA; Conti CJ; Rodriguez-Puebla ML
    Am J Pathol; 2001 Jul; 159(1):369-79. PubMed ID: 11438484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion.
    Thorens B; Guillam MT; Beermann F; Burcelin R; Jaquet M
    J Biol Chem; 2000 Aug; 275(31):23751-8. PubMed ID: 10823833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expansion of the beta-cell compartment in the pancreas of keratinocyte growth factor transgenic mice.
    Wagner M; Koschnick S; Beilke S; Frey M; Adler G; Schmid RM
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1139-47. PubMed ID: 18372394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic co-operation in beta-cell tumorigenesis.
    Pelengaris S; Khan M
    Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.